SyntekaBio Inc (226330) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.098x

Based on the latest financial reports, SyntekaBio Inc (226330) has a cash flow conversion efficiency ratio of -0.098x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.77 Billion ≈ $-1.88 Million USD) by net assets (₩28.34 Billion ≈ $19.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is SyntekaBio Inc worth for the company's overall valuation and market capitalisation.

SyntekaBio Inc - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how SyntekaBio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SyntekaBio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SyntekaBio Inc ranked by their cash flow conversion efficiency. Explore SyntekaBio Inc (226330) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ENERSIDE ENERGY EO -01 F:9O8	N/A
Booster Co. Ltd KQ:008470	-0.010x
Advanced Connection Corporation Public Company Limited BK:ACC	-0.013x
Assura PLC LSE:AGR	0.042x
Oxford Instruments PLC LSE:OXIG	0.155x
Hawthorn Resources Ltd AU:HAW	-0.019x
111 Inc NASDAQ:YI	-3.363x
Allarity Therapeutics Inc NASDAQ:ALLR	-0.330x

Annual Cash Flow Conversion Efficiency for SyntekaBio Inc (2017–2025)

The table below shows the annual cash flow conversion efficiency of SyntekaBio Inc from 2017 to 2025. View SyntekaBio Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩31.78 Billion ≈ $21.54 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.335x	+20.46%
2024-12-31	₩24.94 Billion ≈ $16.90 Million	₩-10.51 Billion ≈ $-7.12 Million	-0.421x	-62.87%
2023-12-31	₩31.23 Billion ≈ $21.16 Million	₩-8.08 Billion ≈ $-5.47 Million	-0.259x	+4.38%
2022-12-31	₩31.46 Billion ≈ $21.32 Million	₩-8.51 Billion ≈ $-5.77 Million	-0.271x	-23.73%
2021-12-31	₩27.63 Billion ≈ $18.72 Million	₩-6.04 Billion ≈ $-4.09 Million	-0.219x	-94.57%
2020-12-31	₩41.54 Billion ≈ $28.15 Million	₩-4.67 Billion ≈ $-3.16 Million	-0.112x	-57.95%
2019-12-31	₩46.11 Billion ≈ $31.25 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.071x	+95.06%
2018-12-31	₩1.64 Billion ≈ $1.11 Million	₩-2.37 Billion ≈ $-1.60 Million	-1.441x	-261.66%
2017-12-31	₩-2.79 Billion ≈ $-1.89 Million	₩-2.49 Billion ≈ $-1.69 Million	0.891x	--

About SyntekaBio Inc

KQ:226330 Korea Health Information Services

Market Cap

$18.74 Million

₩27.65 Billion KRW

Market Cap Rank

#25422 Global

#1878 in Korea

Share Price

₩1140.00

Change (1 day)

-6.79%

52-Week Range

₩1050.00 - ₩5900.00

All Time High

₩43250.00